Biohaven BHVN Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -333%-16.2pp | -310.8%-112pp | —— | -295.9%-102pp | -316.8%-183pp | |
| Return on assets | -140%+62.5pp | -138.5%+11.5pp | -169.7%+10.4pp | -135.4%+1.7pp | -202.5%-103pp | |
| Return on invested capital | -395.4%+152pp | -323.1%-9.4pp | -433.6%-58.4pp | -374.2%+31.0pp | -547.4%-310pp | |
| Liquidity | ||||||
| Current ratio | 7.4×+5.1× | 3.2×-0.3× | 2.9×0.0× | 3.8×+0.5× | 2.3×-1.7× | |
| Quick ratio | 7.4×+5.1× | 3.2×-0.3× | 2.9×0.0× | 3.8×+0.5× | 2.3×-1.7× | |
| Cash ratio | 5.3×+4.7× | 2×+1.3× | 1.7×+1.1× | 1.4×-0.2× | 0.6×-1.5× | |
| Leverage | ||||||
| Debt-to-equity | 2.2×+2.1× | 5.5×+5.4× | —— | 2.2×+2.1× | 0.1×0.0× | |
| Debt-to-assets | 0.6×+0.5× | 0.6×+0.6× | 0.8×+0.7× | 0.5×+0.5× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.88-65.5% | $0.48-89.6% | -$0.16-105% | $1.31-69.9% | $2.55-31.1% | |
| Valuation | ||||||
| Market capitalization | $1.27B-48.1% | $1.5B-60.3% | $1.59B-66.4% | $1.51B-50.8% | $2.45B-45.1% | |
| Enterprise value | $1.28B-46.3% | $1.55B-58.2% | $1.71B-63.3% | $1.63B-42.8% | $2.39B-44.6% | |
| Price / book | 9.8×+0.4× | 28.8×+19.8× | —— | 11.2×+3.2× | 9.5×-5.4× | |
| Free cash flow yield | -46.7%-20.3pp | -40.7%-25.2pp | -41%-29.7pp | -42.9%-27.0pp | -26.5%-18.4pp | |
| Earnings yield | -50.9%-14.7pp | -49.3%-26.9pp | -49.1%-32.1pp | -50.9%-26.5pp | -36.2%-24.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biohaven's ratios come from?
- Every ratio is computed from Biohaven's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.